Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.29202 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.19215 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.19093 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.10589 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.12205 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.28428 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.23366 | 49 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.17061 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.16683 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.1862 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17759 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.12891 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22625 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.18157 | 50 |